Schroder Investment Management Group raised its position in Danaher Co. (NYSE:DHR – Free Report) by 10.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 756,699 shares of the conglomerate’s stock after acquiring an additional 73,045 shares during the quarter. Schroder Investment Management Group owned approximately 0.10% of Danaher worth $173,776,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $27,000. Decker Retirement Planning Inc. purchased a new position in Danaher in the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher during the fourth quarter worth approximately $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the 4th quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its holdings in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insiders Place Their Bets
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 11.10% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Report on Danaher
Danaher Trading Down 2.1 %
Shares of DHR opened at $205.69 on Monday. The firm’s 50-day moving average is $214.57 and its two-hundred day moving average is $236.39. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $147.01 billion, a P/E ratio of 38.96, a PEG ratio of 2.66 and a beta of 0.82.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company posted $2.09 earnings per share. On average, research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- What is a buyback in stocks? A comprehensive guide for investors
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.